Progesterone receptor (PR) governs estrogen signaling in ER+/PR+ breast cancers by dictating chromatin binding of estrogen receptor alpha (ER) [1–3] and modulating the bioavailability of molecules needed for tumor growth [4]. This evidence concerns the gene ESR1 and breast carcinoma.